Standout Papers
Citation Impact
Citing Papers
Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase
2004 StandoutScience
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin
2004
Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment
2013 Standout
Size regulation of von Willebrand factor–mediated platelet thrombi by ADAMTS13 in flowing blood
2005
Shear stress enhances the proteolysis of von Willebrand factor in normal plasma
1994
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding
1997
Programmed cell death in the germline
2005
Von Willebrand factor, platelets and endothelial cell interactions
2003
Reprogramming of human somatic cells to pluripotency with defined factors
2007 StandoutNature
ATM and related protein kinases: safeguarding genome integrity
2003 Standout
Mouse models of cell death
2001
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Electrochemical DNA sensors
2003 Standout
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
IgG4-Related Disease
2012 Standout
Atypical Hemolytic–Uremic Syndrome
2009
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Global Analysis of Gene Expression: Methods, Interpretation, and Pitfalls
2002
Complement: a key system for immune surveillance and homeostasis
2010 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Metabolic Regulation of Oocyte Cell Death through the CaMKII-Mediated Phosphorylation of Caspase-2
2005
Platelets in atherothrombosis
2002
Constitutively active Foxo3 in oocytes preserves ovarian reserve in mice
2013
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
von Willebrand factor.
1997
The development of allergic inflammation
2008 StandoutNature
Neutrophil extracellular traps in immunity and disease
2017 Standout
The variability of female reproductive ageing
2002
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Ageing and apoptosis
2002
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
2000
Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS)
2000
Platelets in inflammation and atherogenesis
2005 Standout
Nonchannel drug targets in atrial fibrillation
2004
Gene Pathways That Delay Caenorhabditis elegans Reproductive Senescence
2014 StandoutNobel
Live or let die: the cell's response to p53
2002 Standout
Human Mast Cell Transcriptome Project
2001
Reflecting on 25 years with MYC
2008 Standout
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
DNA Damage-Induced Primordial Follicle Oocyte Apoptosis and Loss of Fertility Require TAp63-Mediated Induction of Puma and Noxa
2012
IgG4-related disease
2014 Standout
IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
2009
Self-eating and self-killing: crosstalk between autophagy and apoptosis
2007 Standout
Von Willebrand Factor and Von Willebrand Factor-Cleaving Metalloprotease Activity in Escherichia coli O157:H7-Associated Hemolytic Uremic Syndrome
2001
Increased ADAMTS‐13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo
2006
Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura
1998
Small-molecule allosteric inhibitors of BAX
2019
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Mitochondria as multifaceted regulators of cell death
2019 Standout
Disseminated Intravascular Coagulation
1999 Standout
Cytokine Signaling in 2002
2002 Standout
Glycoprotein Ibα and von Willebrand factor in primary platelet adhesion and thrombus formation: Lessons from mutant mice
2008
Consequences of the combined loss of BOK and BAK or BOK and BAX
2013
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Circulating microparticles: pathophysiology and clinical implications
2006
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Cleavage of ultra‐large von Willebrand factor by ADAMTS‐13 under flow conditions
2005
The immunopathogenesis of sepsis
2002 StandoutNature
Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype.
2001
Purification of human von Willebrand factor–cleaving protease and its identification as a new member of the metalloproteinase family
2001
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
von Willebrand factor–mediated platelet adhesion is critical for deep vein thrombosis in mouse models
2010
PAG-3, a Zn-finger transcription factor, determines neuroblast fate inC. elegans
2002 StandoutNobel
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Initial and Cyclic Recruitment of Ovarian Follicles*
2000
Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor
2009 Science
Epinephrine Induces von Willebrand Factor Release from Cultured Endothelial Cells: Involvement of Cyclic AMP-dependent Signalling in Exocytosis
1997
Bcl-x and Bax Regulate Mouse Primordial Germ Cell Survival and Apoptosis during Embryogenesis
2000
Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell–platelet–monocyte interaction
2018
Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis
2001
Jak3 Selectively Regulates Bax and Bcl-2 Expression To Promote T-Cell Development
2001
Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension
2000
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
2000
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Proteolytic Cleavage of Recombinant Type 2A von Willebrand Factor Mutants R834W and R834Q: Inhibition by Doxycycline and by Monoclonal Antibody VP-1
1997
The pro-apoptotic gene Bax is required for the death of ectopic primordial germ cells during their migration in the mouse embryo
2003
Annexins: From Structure to Function
2002 Standout
How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome
2000
Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network
2007
Dioxin-Induced Changes in Epididymal Sperm Count and Spermatogenesis
2009
The TITAN trial – Assessing the efficacy and safety of an anti-von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura
2012
Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion
1996
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Thrombosis: tangled up in NETs
2013
Works of Rodolfo Robles being referenced
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency
1999
Ten years of prophylactic treatment with fresh‐frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor‐cleaving protease
2001
Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.
1993
Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura
1998
The Aryl Hydrocarbon Receptor, a Basic Helix-Loop-Helix Transcription Factor of the PAS Gene Family, Is Required for Normal Ovarian Germ Cell Dynamics in the Mouse
2000
Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis
1996
Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
1997
Recovery and Half-Life of von Willebrand Factor-Cleaving Protease after Plasma Therapy in Patients with Thrombotic Thrombocytopenic Purpura
1999
Partial amino acid sequence of purified von Willebrand factor–cleaving protease
2001
Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura
2002